US Patent Issued to Arvinas Operations, Genentech on Feb. 3 for "BRM targeting compounds and associated methods of use" (Connecticut, New Jersey, California Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,292, issued on Feb. 3, was assigned to Arvinas Operations Inc. (New Haven, Conn.) and Genentech Inc. (South San Francisco, Calif.).

"BRM targeting compounds and associated methods of use" was invented by Andrew P. Crew (Guilford, Conn.), Jing Wang (Milford, Conn.), Michael Berlin (Flemington, N.J.), Peter Dragovich (South San Francisco, Calif.), Huifen Chen (South San Francisco, Calif.) and Leanna Staben (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to bifunctional compounds, which find utility as modulators of SMARCA2 or BRM (target protein). In particular, the present disclosure is direct...